Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin

American Journal of Obstetrics and Gynecology

Volumn 163, Issue 6 PART 2, 1990, Pages 2132-2137

  Bergink, Willem ^a   Assendorp, Roel ^a   Kloosterboer, Lenus ^a   van Lier, Wim ^a   Voortman, Gerrit ^a   Qvist, Ingelise ^b  

^a NV ORGANON   (Netherlands)

^b HORSENS REGIONAL HOSPITAL   (Denmark)

Author keywords

Desogestrel; oral contraceptive; pharmacokinetics; sex hormone binding globulin

Indexed keywords

DESOGESTREL; DESOGESTREL DERIVATIVE; ETHINYLESTRADIOL; SEX HORMONE BINDING GLOBULIN; UNCLASSIFIED DRUG;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL;

CLINICAL RESEARCH; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, ESTROGEN; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, FEMALE--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS, PROGESTIN--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS--PHARMACODYNAMICS; CONTRACEPTIVE METHODS; DEMOGRAPHIC FACTORS; DESOGESTREL--PHARMACODYNAMICS; ETHINYL ESTRADIOL; EXAMINATIONS AND DIAGNOSES; FAMILY PLANNING; GESTODENE; LABORATORY EXAMINATIONS AND DIAGNOSES; LEVONORGESTREL; NORETHINDRONE; ORAL CONTRACEPTIVES; POPULATION; POPULATION DYNAMICS; RESEARCH METHODOLOGY; STUDIES; TIME FACTORS;

ADMINISTRATION, ORAL; ADULT; COMPARATIVE STUDY; CONTRACEPTIVES, ORAL, HORMONAL; DESOGESTREL; ETHINYL ESTRADIOL; FEMALE; HALF-LIFE; HUMAN; LEVONORGESTREL; NORETHINDRONE; NORGESTREL; NORPREGNENES; RADIOIMMUNOASSAY; SEX HORMONE-BINDING GLOBULIN;

EID: 0025604218     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(90)90553-J     Document Type: Article

References (29)

1. Clinical pharmacokinetics of oral contraceptive steroids
2. Variability of pharmacokinetic parameters for contraceptive steroids
3. Pharmacokinetics of contraceptive steroid in humans
4. An investigation of the Pharmacokinetics of ethinyloestradiol in women using radioimmunoassay
5. Pharmacokinetics of ethinyloestradiol: a current view
6. Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulations
7. Variation of ethinylestradiol blood levels among healthy women using oral contraceptives
8. Progestogen Pharmacokinetics and the unknown
9. Pharmacology, Pharmacokinetics and pharmacodynamics; Pharmacokinetics of progestogens
10. Single dose pharmacokinetics of gestodene in women after intravenous and oral administration
11. Effects of d-norgestrel induced decreases in sex hormone binding globulin capacity on the d-norgestrel levels in plasma
12. The Pharmacokinetics of norethindrone in women (1). Radioimmunoassay and concentrations during multiple dosing
13. A versatile method for the determination of serum cortisol binding globulin and sex hormone binding globulin capacities
14. Computer analysis of radio ligand assay and radio immuno assay data
15. A nonchromatographic radioimmunoassay for 3-oxodesogestrel
16. Alterations in the serum level of gestodene and SHBG during 12 cycles of treatment with 30 µg ethinylestradiol and 75 µg gestodene
17. Metabolism of a new synthetic progestagen, Org 2969, in female volunteers. Pharmacokinetics after an oral dose
18. Serum levels of 3ketodesogestrel and SHBG during 12 cycles of treatment with 30 µg ethinylestradiol and 150 µg desogestrel
19. Binding of a contraceptive progestogen Org 2969 and its metabolites to receptor proteins and human sex hor mone binding globulin
20. Plasma levels and Pharmacokinetics of ethinyl estrogens in various populations I Ethynyl estradiol
21. Plasma levels and Pharmacokinetics of norethindrone and ethinyl estradiol administered in solution and as tablets to women
22. Investigations of Pharmacokinetics of ethinyloestradiol to specific consideration of a possible first-pass effect in women
23. The Pharmacokinetics of levonorgestrel and ethinyloestradiol in women—studies with Ovran and Ovranette
24. Investigations of Pharmacokinetics of levonorgestrel to specific considerations of a possible first-pass effect in women
25. Serum levels of 3-ketodesogestrel after oral administration of desogestrel and 3-ketodesogestrel
26. Plasma concentrations of 3-ketodesogestrel after oral administration of desogestrel and intravenous administration of 3-ketodesogestrel
27. The relative bioavailability of levonorgestrel and ethinyl oestradiol when administered in tablet and capsule form
28. The Pharmacokinetics of norethindrone in women (2). Single dose Pharmacokinetics